The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AEGERION PHARMACEUTICALS, INC. | COMMON | 00767E102 | 38,815 | 547,001 | SH | SOLE | 547,001 | 0 | 0 | ||
FIVE BELOW, INC. | COMMON | 33829M101 | 199,672 | 4,622,261 | SH | SOLE | 4,622,261 | 0 | 0 | ||
VANTIV, INC. | COMMON | 92210H105 | 612,453 | 18,781,147 | SH | SOLE | 18,781,147 | 0 | 0 |